SEARCH RESULTS FOR: "Tag: GILD"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2020(10)
2019(6)
2018(8)
2017(26)
2016(38)
2015(31)
2014(16)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(11)
Analyst Update(19)
Analyst Upgrades(8)
Bernie's Content(1)
Best and Worst Stocks(1)
Buzz Stocks(15)
By the Numbers(3)
Earnings Preview(5)
Editor's Pick(2)
Expectational Analysis(2)
General(22)
Intraday Option Activity(17)
Market Recap(4)
Midday Market Check(1)
Most Active Options Update(2)
Most Active Weekly Options(2)
Opening View(12)
Quantitative Analysis(1)
Stock Market News(4)
Stocks On the Move(17)
Technical Analysis(1)
The Week Ahead(3)
Trader Content(1)

6/29/2020 10:22 AM
Gilead Sciences, Inc. (NASDAQ:GILD) announced pricing for its coronavirus treatment remdesivir. The drugmaker said it will sell remdesivir to the governments of developed countries for $390 per vial...
4/29/2020 4:35 PM
The Dow marked a healthy session, up over 530 points, as investors cheered upbeat trial data from Gilead Science's (GILD) potential coronavirus treatment. In fact, all three major indexes managed t...
4/29/2020 3:18 PM
Gilead Sciences, Inc (NASDAQ:GILD) has been the darling of Wall Street today, after a study conducted by the National Institute of Allergy and Infectious Diseases found that its experimental coronavi...
4/23/2020 4:38 PM
The Dow scraped together a 40-point win, as earlier gains were slashed after documents were published on Gilead Science's (GILD) potential coronavirus treatment remdesivir, which drew disappointing ...
4/17/2020 10:07 AM
Shares of Gilead Sciences, Inc. (NASDAQ:GILD) are surging, last seen up 10.6%, at $84.66, after an encouraging report suggested the biotech company’s antiviral medication remdesivir may be effective...

Partnercenter